Cargando…
Potential Agents against Plasma Leakage
Shock due to severe plasma leakage may happen in infectious diseases such as severe dengue and sepsis due to various bacterial infections, which may be deleterious and may lead to death. Various substances and proteins are known to modulate the effects of proleakage mediators and counteract the dele...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195382/ https://www.ncbi.nlm.nih.gov/pubmed/22084722 http://dx.doi.org/10.5402/2011/975048 |
_version_ | 1782214122669080576 |
---|---|
author | Pawitan, Jeanne Adiwinata |
author_facet | Pawitan, Jeanne Adiwinata |
author_sort | Pawitan, Jeanne Adiwinata |
collection | PubMed |
description | Shock due to severe plasma leakage may happen in infectious diseases such as severe dengue and sepsis due to various bacterial infections, which may be deleterious and may lead to death. Various substances and proteins are known to modulate the effects of proleakage mediators and counteract the deleterious effect of plasma leakage. Some of the various substances and proteins such as focal adhesion kinase (FAK), the Rho GTPases, protein kinase A, and caveolin-1 have dual actions; therefore they are not suitable for therapy. However, sphingosine 1phosphate and its receptor agonists, Angiopoetin-1, Slit, and Bbeta15–42 may be promising. |
format | Online Article Text |
id | pubmed-3195382 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | International Scholarly Research Network |
record_format | MEDLINE/PubMed |
spelling | pubmed-31953822011-11-14 Potential Agents against Plasma Leakage Pawitan, Jeanne Adiwinata ISRN Pharmacol Review Article Shock due to severe plasma leakage may happen in infectious diseases such as severe dengue and sepsis due to various bacterial infections, which may be deleterious and may lead to death. Various substances and proteins are known to modulate the effects of proleakage mediators and counteract the deleterious effect of plasma leakage. Some of the various substances and proteins such as focal adhesion kinase (FAK), the Rho GTPases, protein kinase A, and caveolin-1 have dual actions; therefore they are not suitable for therapy. However, sphingosine 1phosphate and its receptor agonists, Angiopoetin-1, Slit, and Bbeta15–42 may be promising. International Scholarly Research Network 2011 2011-04-03 /pmc/articles/PMC3195382/ /pubmed/22084722 http://dx.doi.org/10.5402/2011/975048 Text en Copyright © 2011 Jeanne Adiwinata Pawitan. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Pawitan, Jeanne Adiwinata Potential Agents against Plasma Leakage |
title | Potential Agents against Plasma Leakage |
title_full | Potential Agents against Plasma Leakage |
title_fullStr | Potential Agents against Plasma Leakage |
title_full_unstemmed | Potential Agents against Plasma Leakage |
title_short | Potential Agents against Plasma Leakage |
title_sort | potential agents against plasma leakage |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195382/ https://www.ncbi.nlm.nih.gov/pubmed/22084722 http://dx.doi.org/10.5402/2011/975048 |
work_keys_str_mv | AT pawitanjeanneadiwinata potentialagentsagainstplasmaleakage |